Φορτώνει......
Biomarker predictors for immunotherapy benefit in breast: beyond PD-L1
PURPOSE OF REVIEW: Immune checkpoint blockade (ICB) has changed the clinical course of multiple cancer types and durable responses have now been observed in breast cancer (BC) patients. Most data suggest that, compared to other subtypes, triple-negative BC (TNBC) patients are more responsive to ICB,...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Curr Breast Cancer Rep |
|---|---|
| Κύριοι συγγραφείς: | , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
2019
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7731906/ https://ncbi.nlm.nih.gov/pubmed/33312343 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12609-019-00331-5 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|